About Dr. Divya Bansal

Overview

• Dr. Divya Bansal is a HOD – Consultant in Clinical Hematology and Bone Marrow Transplant (BMT) at Manipal Hospitals, Dwarka, New Delhi. With a distinguished academic background and extensive clinical experience, Dr. Bansal is a leading figure in the field of haematology. She completed her MBBS and DNB in Paediatrics from Sir Ganga Ram Hospital (SGRH) and further specialised with a DM in Clinical Hematology from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. Her international training includes a tenure as a Consultant of Hematology at St. Mary’s Hospital, Imperial College of London NHS Trust, London, UK.
• Dr. Bansal’s expertise covers a wide range of hematological conditions and treatments. She specialises in hematopoietic stem cell transplants, including autologous and allogeneic transplants for conditions such as multiple myeloma, lymphomas, germ cell tumours, and immunological disorders like multiple sclerosis. Additionally, she is proficient in managing benign disorders such as thalassemia, sickle cell anaemia, aplastic anaemia, and bone marrow failure syndromes.
• Actively involved in research, Dr. Bansal best Hematology consultant has numerous publications and presentations to her credit. She has received several awards, including the National Neonatology Quiz and the National Pediatric Hematology Organization (NPHO) Thalassemia Chelation debate. Her contributions to the field are well-recognized, and she continues to stay updated with the latest advancements in haematology.
• Dr. Bansal is a life member of several esteemed organizations, including the Indian Society of Hematology and Blood Transfusion (ISHBT), the American Society of Hematology (ASH), the Indian Medical Association (IMA), and the Delhi Medical Association (DMA). Her commitment to her field is evident in her continuous efforts to provide the best possible care to her patients.
• Patients and colleagues commend Dr. Bansal for her compassionate approach and expertise in handling complex cases. Her dedication to patient-centered care has significantly impacted patient outcomes, particularly in bone marrow transplantation. For those seeking specialized care in haematology, Dr. Divya Bansal’s extensive knowledge, experience, and patient-centred approach make her an excellent choice.

Field of Expertise

• Hematopoietic Stem Cell Transplant (BMT): Autologous, Allogenic (MSD, MUD, Haploidentical transplants)
• Autologous BMT for Multiple Myeloma, Lymphomas, Germ cell tumors, cutaneous lymphomas, immunological disorders like Multiple Sclerosis, etc.
• Allogenic BMT for benign disorders like Thalassemia, Sickle cell anemia, Aplastic anemia, bone marrow failure syndromes
• Allogenic BMT for malignant disorders
• Hematological disease management
• Acute Leukemia and chronic leukemia like CML, CLL
• Plasma cell Dijscrasias (Multiple Myeloma WM, Amyloidosis)
• Hemoglobinopathies (Thalassemia’s, Sickle Cell Disease, and other red cell disorders)
• Hemophilia & bleeding disorders
• Aplastic Anemia & Bone Marrow Failure Syndrome
• ITP and Thrombocytopenia
• Nutritional Anemia (IDA, Megaloblastic Anemia)
• Lymphomas (HL, NHL)
• Pediatric Hematological Disorders

Fellowship & Membership

• Life Member of the Indian Society of Hematology & Blood Transfusion (ISHBT).
• Member of the American Society of Hematology (ASH).
• Life Member of the Indian Medical Association (IMA).
• Life member of Delhi Medical Association (DMA).

Languages Spoken

• English
• Hindi

Awards & Achievements

• Winners of National Neonatology Quiz.
• Winner of National Pediatric Hematology organization (NPHO) Thalassemia Chelation debate.

Talks & Publications

• Dr. Divya Bansal in an authored article carefully explains each type of cancer and its treatment in the DNA today.Click Here
• Dr. Divya Bansal & Team save 9-year-old Iraqi girl with rare blood disorders in The Times of India | Exclusive Story.Click Here
• Dr. Divya Bansal on a Life-saving Bone Marrow Transplant Giving a new lease of Life to a Patient with a rare medical condition in Financial Express -Exclusive story.Click Here